ESG Focus PCI Pharma Services has demonstrated a commitment to Environmental, Social, and Governance (ESG) principles by releasing its first ESG Report. This focus on sustainability presents a significant sales opportunity for partnering with companies looking for CDMOs aligned with responsible practices.

Expansion into Ireland With the recent expansion of packaging operations in Ireland, PCI Pharma Services has paved the way for increased market presence in Europe. This expansion signifies a strategic opportunity for European companies seeking reliable drug development and packaging solutions.

Technological Advancements PCI Pharma Services utilizes cutting-edge technologies such as Amazon Web Services and iOS in its operations. This technological sophistication presents a sales opportunity for tech-driven companies looking to collaborate with a CDMO at the forefront of innovation.

Capacity Expansion By investing $100 million in expanding capabilities at its Bedford campus, PCI Pharma Services has positioned itself as a key player in aseptic liquid fill-finish and sterile lyophilization technology. This expansion creates sales opportunities for companies in need of such specialized manufacturing processes.

Strategic Facility Expansion The expansion of facilities into Coffeyville, Kansas, signals PCI Pharma's strategic move into the Midwest and its plans for a biologics assembly facility. This geographical expansion opens up sales opportunities for companies seeking partnerships in biologics manufacturing in the heart of the United States.